Ribavirin in crimean-congo hemorrhagic fever: Primum non nocere

Clinical Infectious Diseases

Volumn 49, Issue 10, 2009, Pages 1621-1622

  Ergönül, Önder ^a   ÇelikbaŞ, Aysel ^b   Dokuzoǧuz, Başak ^b   Eren, Şebnem ^b   Baykam, Nurcan ^b   Esener, Harika ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ANALYTICAL ERROR; CLINICAL PRACTICE; CRIMEAN CONGO HEMORRHAGIC FEVER; DRUG EFFICACY; FATALITY; HEALTH CARE PERSONNEL; HEMORRHAGIC FEVER; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; SAMPLE SIZE;

ANTIVIRAL AGENTS; BIAS (EPIDEMIOLOGY); HEMORRHAGIC FEVER, CRIMEAN; HUMANS; RIBAVIRIN; STATISTICS AS TOPIC; TURKEY;

EID: 72849142205     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644778     Document Type: Letter

References (6)

1. ErgÖnül O, ÇelikbaŞ A, Dokuzoǧuz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004; 39: 284-287
2. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congohaemorrhagic fever treated with oral ribavirin. Lancet 1995; 346:472-475
3. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 2003; 36:1613-1618 (Pubitemid 36783348) (Pubitemid 36783348)
4. European Centre for Disease Prevention and Control (ECDC). Consultation on Crimean-Congo hemorrhagic fever prevention and control. Stockholm: ECDC, 2008.
5. Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis 2009; 28:929-933
6. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res 2008; 78:125-131